Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by VAN KARLYLE MORRIS and EDMUND SCOTT KOPETZ.
VAN KARLYLE MORRIS
Connection Strength
1.485
EDMUND SCOTT KOPETZ
  1. Progression-free survival remains poor over sequential lines of systemic therapy in patients with BRAF-mutated colorectal cancer. Clin Colorectal Cancer. 2014 Sep; 13(3):164-71.
    View in: PubMed
    Score: 0.502
  2. BRAF inhibitors in clinical oncology. F1000Prime Rep. 2013; 5:11.
    View in: PubMed
    Score: 0.462
  3. Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer. J Clin Oncol. 2015 Dec 01; 33(34):4032-8.
    View in: PubMed
    Score: 0.137
  4. Association between KRAS mutation and lung metastasis in advanced colorectal cancer. Br J Cancer. 2015 Feb 03; 112(3):424-8.
    View in: PubMed
    Score: 0.130
  5. Src activity is modulated by oxaliplatin and correlates with outcomes after hepatectomy for metastatic colorectal cancer. BMC Cancer. 2014 Sep 10; 14:660.
    View in: PubMed
    Score: 0.128
  6. Clinicopathologic characteristics and gene expression analyses of non-KRAS 12/13, RAS-mutated metastatic colorectal cancer. Ann Oncol. 2014 Oct; 25(10):2008-2014.
    View in: PubMed
    Score: 0.126
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.